Drug class
First-generation alkylamine antihistamine; histamine H1 receptor antagonist
Mechanism of action
Competitively antagonises peripheral H1 histamine receptors, reducing histamine-mediated vasodilation, vascular permeability, itching and allergic symptoms. It can also produce sedative and anticholinergic effects.
General use cases
- Symptomatic relief of allergic rhinitis, urticaria, pruritus and allergic conjunctivitis in countries where mepyramine products are authorised; topical formulations have separate local-use indications
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
